Skip to content
Independent analysis of NHS open data
PharmaInsight

Tofacitinib

Musculoskeletal and Joint Diseases Drugs used in rheumatic diseases and gout BNF 1001030AB
Data updated March 2026 Download CSV
1items

Dispensed in March 2026

1items

Rolling 12 months

£12

Net ingredient cost · March 2026

Figure 1. Tofacitinib: national items dispensed by month

0 1.5 3 Jan 2021 Sep 2021 Dec 2021 Dec 2022 Jan 2024 Mar 2026 1 Jan 2021: 2 Aug 2021: 1 Sep 2021: 3 Nov 2021: 1 Dec 2021: 1 Mar 2022: 1 Dec 2022: 1 Dec 2023: 1 Jan 2024: 1 Apr 2025: 1 May 2025: 1 Mar 2026: 1

Source: NHSBSA Prescription Cost Analysis, to March 2026

Download CSV
Embed this chart

At a glance

  • Therapeutic class Drugs used in rheumatic diseases and gout
  • Presentations 1 shown
  • Average cost / item £12.32
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, March 2026

The individual products dispensed under Tofacitinib this month.

Presentations of Tofacitinib, March 2026
Presentation BNF code Items Net ingredient cost
Xeljanz 5mg tablets 1001030ABBBAAAB 1 £12

Source: NHSBSA Prescription Cost Analysis · to March 2026 OGL v3.0

Where Tofacitinib is dispensed

The regions and dispensing practices with the highest Tofacitinib volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

In NHS hospitals

Tofacitinib is also used in NHS secondary care. See the indicative hospital cost, monthly trend and the trusts using it most on the hospital medicines page.

Compare Tofacitinib with

Other medicines in the same BNF section, by prescribing volume.